Famotidine: a supplemental drug for the treatment of schizophrenia

Author： Dannon P. Lepkifker E. Iancu I. Ziv R. Horesh N. Kotler M.

Publisher： Elsevier

ISSN： 0924-9338

Source： European Psychiatry, Vol.12, Iss.5, 1997-01, pp. : 263-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the drug treatment of schizophrenia

By McCreadie Robin G.

Primary Care Psychiatry, Vol. 6, Iss. 1, 2000-03 ,pp. : 9-14

Informa Healthcare

Access to resources Recommend Favorite

Glucose Metabolism in Relation to Schizophrenia and Antipsychotic Drug Treatment

By Dwyer D.S.

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 2, 2001-06 ,pp. : 103-113

Springer Publishing Company

Access to resources Recommend Favorite

Antipsychotic Drug Doses and Adjunctive Drugs in the Outpatient Treatment of Schizophrenia

By Galletly C.A.

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 09, Iss. 2, 1997-06 ,pp. : 77-80

Springer Publishing Company

Access to resources Recommend Favorite

Prepsychotic Treatment for Schizophrenia: Preventive Medicine, Social Control, or Drug Marketing Strategy?

By Gosden Richard

Ethical Human Sciences and Services, Vol. 1, Iss. 2, 1999-01 ,pp. : 165-177

Springer Publishing Company

Access to resources Recommend Favorite

Interferon Status during the Treatment of Drug Resistant Patients with Paranoid Schizophrenia

By Maruta N. Rachkauskas G. Frolov V. Vysochin E.

Neuroscience and Behavioral Physiology, Vol. 43, Iss. 6, 2013-07 ,pp. : 697-699

Springer Publishing Company

Access to resources Recommend Favorite